BFA
CBST

BlackRock Fund Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BlackRock Fund Advisors’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,072,898
Closed -$309M – 3815
2014
Q4 		$309M Sell
3,072,898
-39,075
-1% -$3.04M 0.08% 270
2014
Q3 		$206M Buy
3,111,973
+129,223
+4% +$8.49M 0.06% 375
2014
Q2 		$208M Buy
2,982,750
+127,225
+4% +$8.65M 0.06% 374
2014
Q1 		$209M Sell
2,855,525
-14,366
-0.5% -$1.07M 0.06% 350
2013
Q4 		$198M Buy
2,869,891
+492,875
+21% +$31.9M 0.06% 369
2013
Q3 		$151M Sell
2,377,016
-291,755
-11% -$17.6M 0.05% 462
2013
Q2 		$129M Buy
+2,668,771
New +$131M 0.05% 478

BlackRock Fund Advisors's CBST Position: Q1 2015 in Review

BlackRock Fund Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 3,072,898 shares — an estimated $309M sold.

BlackRock Fund Advisors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $309M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BlackRock Fund Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 3,072,898 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $309M.
  • BlackRock Fund Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Fund Advisors's CUBIST PHARMACEUTICALS INC position peaked at $309M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Fund Advisors's 13F filing for Q1 2015, filed 13 May 2015.